ABBVIE INC.

Trials

Studies that name ABBVIE INC. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:31 UTC. Showing 200 of 860. Open this list on ClinicalTrials.gov

• Ph1
  NCT07925983 · A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants

  AbbVie · recruiting · Healthy Volunteer · study director
• Ph2
  NCT07904754 · Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis

  AbbVie · not yet recruiting · Rheumatoid Arthritis · study director
• N/A
  NCT07896421 · Real-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and Peritoneal Cancer

  AbbVie · recruiting · Platinum-Resistant FRα-Positive Ovarian Cancer, Platinum-Resistant FRα-Positive Fallopian Tube Cancer, Platinum-Resistant FRα-Positive Peritoneal Cancer · study director
• Ph3
  NCT07896434 · A Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental Vitiligo

  AbbVie · not yet recruiting · Non-Segmental Vitiligo · study director
• Ph2
  NCT07895056 · A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and Atezolizumab in Adult Participants With Extensive Stage-Small Cell Lung Cancer

  AbbVie · not yet recruiting · Extensive Stage-Small Cell Lung Cancer · study director
• Ph2
  NCT07895043 · A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and Atezolizumab for Adults Participants With Extensive Stage-Small Cell Lung Cancer

  AbbVie · not yet recruiting · Extensive Stage-Small Cell Lung Cancer (ES-SCLC) · study director
• Ph3
  NCT07880756 · Safety and Effectiveness of NOA HYDRATION Injectable Gel for the Improvement of Skin Quality Including Attributes Such as Skin Smoothness

  AbbVie · recruiting · Skin Quality · study director
• Ph2
  NCT07871513 · A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines

  AbbVie · recruiting · Upper Facial Lines, Glabellar Lines · study director
• N/A
  NCT07862764 · A Study to Assess Change in Disease State and Adverse Events in Korean Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) Receiving Epcoritamab Injections

  AbbVie · not yet recruiting · Diffuse Large B-Cell Lymphoma · study director
• Ph1
  NCT07856706 · A Single Ascending Dose, and Food Effect Study of ABBV-7828 in Healthy Adults

  AbbVie · recruiting · Healthy Subjects · study director
• Ph1
  NCT07843693 · A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers

  AbbVie · recruiting · Healthy Volunteers · study director
• Ph1
  NCT07832708 · Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults

  AbbVie · not yet recruiting · Healthy Volunteers · study director
• Ph3
  NCT07821684 · A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

  AbbVie · not yet recruiting · Non-Squamous Non-Small Cell Lung Cancer · study director
• Ph1
  NCT07807956 · A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

  AbbVie · recruiting · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer · study director
• Ph3
  NCT07794878 · Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds in Adults

  AbbVie · recruiting · Nasolabial Folds · study director
• Ph4
  NCT07794891 · Study to Assess Participant Satisfaction After Jawline and Neck Treatment

  AbbVie · recruiting · Jawline and Neck Appearance · study director
• Ph3
  NCT07793422 · Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) Amyloidosis

  AbbVie · not yet recruiting · Amyloid Light Chain (AL) Amyloidosis · study director
• Ph3
  NCT07772492 · A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

  AbbVie · recruiting · Severe Alopecia Areata · study director
• Ph2
  NCT07769502 · A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers

  AbbVie · recruiting · Pancreatobiliary Cancers, Pancreatic Ductal Adenocarcinoma · study director
• Ph3
  NCT07756645 · A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants

  AbbVie · recruiting · Non-Small Cell Lung Cancer · study director
• Ph1
  NCT07756580 · A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines

  AbbVie · active not recruiting · Glabellar Lines · study director
• Ph2
  NCT07752979 · Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  AbbVie · recruiting · Obesity, Overweight · study director
• Ph2
  NCT07744126 · A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  AbbVie · recruiting · Head and Neck Squamous Cell Carcinoma · study director
• N/A
  NCT07741838 · Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)

  AbbVie · not yet recruiting · Atopic Dermatitis · study director
• Ph1
  NCT07736638 · A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants

  AbbVie · recruiting · Healthy Volunteer · study director
• Ph2
  NCT07730554 · A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants

  AbbVie · active not recruiting · Forehead Lines · study director
• Ph3
  NCT07728188 · A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  AbbVie · not yet recruiting · Relapsed or Refractory Multiple Myeloma · study director
• Ph2
  NCT07697456 · Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  AbbVie · recruiting · Crohn's Disease, Ulcerative Colitis · study director
• N/A
  NCT07690215 · Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom

  AbbVie · not yet recruiting · Migraine · study director
• N/A
  NCT07687602 · A Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting

  AbbVie · not yet recruiting · Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian Cancer, Folate Receptor-Alpha Positive Platinum-Resistant Fallopian Tube Cancer, Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer · study director
• Ph1
  NCT07680686 · Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants

  AbbVie · active not recruiting · Healthy Volunteer · study director
• Ph1
  NCT07673120 · A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants

  AbbVie · recruiting · Healthy Volunteers · study director
• Ph2
  NCT07673107 · Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor

  AbbVie · recruiting · Upper Limb Essential Tremor · study director
• Ph1
  NCT07649954 · A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT07607964 · A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

  AbbVie · recruiting · Systemic Lupus Erythematosus, Rheumatoid Arthritis · study director
• Ph1
  NCT07600762 · A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants

  AbbVie · completed · Healthy Volunteer · study director
• N/A
  NCT07604545 · A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema

  AbbVie · withdrawn · Diabetic Macular Edema · study director
• Ph1
  NCT07604558 · A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1/Ph2
  NCT07599670 · A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

  AbbVie · recruiting · Alzheimer's Disease · study director
• Ph1
  NCT07599761 · A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph2/Ph3
  NCT07592273 · Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

  AbbVie · recruiting · Diabetic Retinopathy · study director
• Ph1
  NCT07587008 · Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult Healthy Volunteers

  AbbVie · completed · Healthy Volunteers · study director
• Ph2/Ph3
  NCT07581002 · A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  AbbVie · recruiting · Acute Myeloid Leukemia · study director
• Ph1
  NCT07570147 · A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants

  AbbVie · recruiting · Healthy Volunteer · study director
• Ph1
  NCT07567781 · A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

  AbbVie · completed · Healthy Volunteers · study director
• Ph1
  NCT07566130 · A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• N/A
  NCT07539844 · Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries

  AbbVie · recruiting · Ovarian Cancer · study director
• Ph3
  NCT07525206 · A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

  AbbVie · recruiting · Colorectal Cancer · study director
• Ph1
  NCT07514260 · A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

  AbbVie · active not recruiting · Healthy Volunteer · study director
• Ph1
  NCT07502417 · A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph2/Ph3
  NCT07490301 · A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

  AbbVie · recruiting · Metastatic Pancreatic Ductal Adenocarcinoma, PDAC · study director
• Ph1
  NCT07466550 · A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants

  AbbVie · recruiting · Healthy Volunteer · study director
• Ph1
  NCT07425899 · A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• N/A
  NCT07421258 · A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

  AbbVie · completed · Crohn's Disease, Ulcerative Colitis · study director
• N/A
  NCT07419347 · Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

  AbbVie · recruiting · Hepatitis C Virus (HCV) · study director
• Ph1
  NCT07414784 · A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT07413133 · A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT07409246 · A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

  AbbVie · recruiting · Multiple Myeloma · study director
• N/A
  NCT07407062 · A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy

  AbbVie · recruiting · Cancer - Ovarian · study director
• Ph2
  NCT07387471 · Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

  AbbVie · active not recruiting · Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma · study director
• N/A
  NCT07382440 · A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

  AbbVie · recruiting · Parkinson's Disease · study director
• Ph3
  NCT07365241 · A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  AbbVie · recruiting · Small Cell Lung Cancer · study director
• Ph1
  NCT07361367 · A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• N/A
  NCT07310290 · Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

  AbbVie · recruiting · Migraine · study director
• N/A
  NCT07310277 · Expanded Access to ABBV-706

  AbbVie · available · Small Cell Lung Cancer · study director
• Ph1
  NCT07306754 · A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

  AbbVie · recruiting · Healthy Volunteers · study director
• Ph1
  NCT07306832 · A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

  AbbVie · recruiting · Acute Myeloid Leukemia · study director
• Ph1
  NCT07291232 · A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity

  AbbVie · active not recruiting · Obesity · study director
• Ph3
  NCT07284381 · A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease

  AbbVie · completed · Dry Eye Disease · study director
• N/A
  NCT07284342 · A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

  AbbVie · recruiting · Advanced Parkinson's Disease · study director
• Ph1
  NCT07278336 · A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

  AbbVie · recruiting · Ovarian Cancer · study director
• Ph2
  NCT07276997 · A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

  AbbVie · recruiting · Major Depressive Disorder · study director
• Ph1
  NCT07241039 · A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

  AbbVie · recruiting · Advanced Squamous Tumors · study director
• Ph1
  NCT07232004 · A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections

  AbbVie · active not recruiting · Healthy Volunteer, Psoriasis · study director
• Ph2
  NCT07230288 · Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  AbbVie · recruiting · Idiopathic Pulmonary Fibrosis · study director
• N/A
  NCT07227896 · Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

  AbbVie · recruiting · Parkinson's Disease · study director
• Ph2
  NCT07226791 · Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

  AbbVie · recruiting · Ventral Hernia · study director
• Ph1
  NCT07222709 · A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph2
  NCT07220460 · Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

  AbbVie · active not recruiting · Bipolar I or II Disorder · study director
• Ph1
  NCT07219030 · A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

  AbbVie · recruiting · Healthy Volunteer · study director
• Ph1
  NCT07219017 · A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph3
  NCT07207369 · A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

  AbbVie · recruiting · Acne Scars · study director
• Ph2
  NCT07196644 · A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

  AbbVie · recruiting · Solid Tumors Harboring MET Amplification · study director
• Ph4
  NCT07186595 · A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance

  AbbVie · completed · Mid Face Volume Deficit · study director
• Ph1/Ph2
  NCT07160179 · Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  AbbVie · recruiting · Geographic Atrophy, Age-Related Macular Degeneration · study director
• N/A
  NCT07158827 · Expanded Access to Tavapadon

  AbbVie · no longer available · Parkinson Disease · study director
• Ph2
  NCT07155174 · A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

  AbbVie · recruiting · Small Cell Lung Cancer · study director
• Ph2/Ph3
  NCT07155187 · A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  AbbVie · recruiting · Non-Small Cell Lung Cancer, c-MET · study director
• Ph2
  NCT07145918 · A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

  AbbVie · recruiting · Schizophrenia · study director
• Ph1
  NCT07141199 · A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers

  AbbVie · completed · Healthy Volunteer · study director
• N/A
  NCT07136467 · A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

  AbbVie · recruiting · Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa · study director
• N/A
  NCT07136116 · Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

  AbbVie · recruiting · Ulcerative Colitis · study director
• Ph1
  NCT07136103 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph4
  NCT07122583 · A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System

  AbbVie · completed · Non-Surgical Fat Reduction · study director
• Ph2/Ph3
  NCT07095452 · A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

  AbbVie · recruiting · Multiple Myeloma · study director
• N/A
  NCT07073079 · A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting

  AbbVie · recruiting · Crohn's Disease · study director
• Ph3
  NCT07071519 · A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  AbbVie · recruiting · Ulcerative Colitis · study director
• Ph1
  NCT07071532 · A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder

  AbbVie · recruiting · Bipolar Disorder · study director
• Ph2
  NCT07059845 · A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  AbbVie · recruiting · Ovarian Cancer · study director
• N/A
  NCT07058051 · Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

  AbbVie · completed · Non-Segmental Vitiligo · study director
• Ph4
  NCT07044687 · Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

  AbbVie · recruiting · Acute Myeloid Leukemia · study director
• N/A
  NCT07039110 · Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

  AbbVie · recruiting · Plaque Psoriasis · study director
• Ph3
  NCT07032597 · A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants

  AbbVie · completed · Mid Face Volume Deficit · study director
• Ph1
  NCT07027527 · An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

  Apogee Therapeutics, Inc. · active not recruiting · Atopic Dermatitis · study director
• Ph2
  NCT07024784 · A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  AbbVie · recruiting · Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer · study director
• Ph1
  NCT07024797 · Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph2
  NCT07023289 · A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

  AbbVie · recruiting · Colorectal Cancer · study director
• Ph3
  NCT07023302 · A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

  AbbVie · active not recruiting · Alopecia Areata · study director
• Ph1
  NCT07007091 · A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph2/Ph3
  NCT07005102 · A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  AbbVie · recruiting · Non-Squamous Non-Small Cell Lung Cancer, c-MET · study director
• Ph3
  NCT07007065 · Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  AbbVie · recruiting · Neovascular Age-related Macular Degeneration · study director
• Ph2
  NCT07003425 · A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  Apogee Therapeutics, Inc. · recruiting · Atopic Dermatitis · study director
• Ph1
  NCT06977724 · A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

  AbbVie · recruiting · Dry Eye Syndrome, Systemic Lupus Erythematosus · study director
• Ph2
  NCT06972446 · A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

  AbbVie · recruiting · Rheumatoid Arthritis · study director
• N/A
  NCT06965374 · Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

  AbbVie · recruiting · Parkinson Disease · study director
• Ph1/Ph2
  NCT06953960 · A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  AbbVie · recruiting · Multiple Myeloma · study director
• Ph1
  NCT06953934 · A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT06946524 · A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph1
  NCT06937619 · A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• N/A
  NCT06937034 · Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

  AbbVie · recruiting · Parkinson's Disease · study director
• Ph1
  NCT06920901 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma

  Apogee Therapeutics, Inc. · active not recruiting · Asthma · study director
• N/A
  NCT06916507 · Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

  AbbVie · recruiting · Parkinson's Disease · study director
• Ph1
  NCT06896916 · Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

  AbbVie · recruiting · Multiple Myeloma · study director
• Ph1
  NCT06895356 · A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT06895343 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous or Intravenous Doses of ABBV-701 in Healthy Adult Western and Asian Participants

  AbbVie · active not recruiting · Healthy Volunteer · study director
• Ph1/Ph2
  NCT06892522 · A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

  AbbVie · recruiting · Multiple Myeloma · study director
• Ph2
  NCT06890338 · A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  AbbVie · recruiting · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer · study director
• Ph1
  NCT06887010 · A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph3
  NCT06880744 · A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

  AbbVie · active not recruiting · Ulcerative Colitis · study director
• Ph2
  NCT06865105 · Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

  AbbVie · recruiting · Psoriatic Arthritis · study director
• Ph1
  NCT06858813 · A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

  AbbVie · recruiting · Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer · study director
• Ph1
  NCT06849791 · A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph2
  NCT06846320 · Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

  AbbVie · recruiting · Generalized Anxiety Disorder (GAD) · study director
• N/A
  NCT06838845 · An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

  AbbVie · recruiting · Ulcerative Colitis · study director
• Ph1
  NCT06834789 · A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

  AbbVie · completed · Glabellar Lines · study director
• N/A
  NCT06830759 · Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  AbbVie · recruiting · Diffuse Large B-cell Lymphoma, Follicular Lymphoma · study director
• Ph3
  NCT06822738 · A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

  AbbVie · recruiting · Primary Open Angle Glaucoma · study director
• Ph2
  NCT06820463 · A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

  AbbVie · recruiting · Metastatic Colorectal Cancer · study director
• Ph3
  NCT06810505 · A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  AbbVie · recruiting · Chronic Migraine · study director
• Ph3
  NCT06806293 · Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  AbbVie · active not recruiting · Menstrual Migraine (MM) · study director
• Ph3
  NCT06794866 · A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants

  AbbVie · completed · Forehead Lines · study director
• Ph4
  NCT06783621 · A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

  AbbVie · completed · Facial Contouring · study director
• Ph1
  NCT06774313 · A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1/Ph2
  NCT06772623 · Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

  AbbVie · recruiting · Non Small Cell Lung Carcinoma, c-MET · study director
• N/A
  NCT06764706 · Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

  AbbVie · recruiting · Ulcerative Colitis · study director
• N/A
  NCT06764693 · An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  AbbVie · recruiting · Psoriatic Arthritis · study director
• Ph1
  NCT06742086 · A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Healthy Adult Female Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph3
  NCT06734351 · A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

  AbbVie · recruiting · Mid Face Volume Deficit · study director
• Ph1
  NCT06722430 · A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT06722417 · A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph2
  NCT06718101 · A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

  AbbVie · active not recruiting · Atopic Dermatitis · study director
• N/A
  NCT06712628 · A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

  AbbVie · recruiting · Moderate to Severe Rheumatoid Arthritis · study director
• Ph3
  NCT06701331 · Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis

  AbbVie · active not recruiting · Atopic Dermatitis · study director
• Ph1
  NCT06698926 · A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph2
  NCT06696755 · A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

  AbbVie · recruiting · Bipolar I Disorder, Bipolar II Disorder · study director
• N/A
  NCT06692881 · Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

  AbbVie · completed · Migraine · study director
• Ph2
  NCT06682988 · A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

  AbbVie · recruiting · Advanced High-Grade Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancers · study director
• Ph1
  NCT06673238 · A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants

  AbbVie · completed · Healthy Volunteer · study director
• Ph1
  NCT06667687 · Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

  AbbVie · active not recruiting · Non-Hodgkin's Lymphoma · study director
• N/A
  NCT06639620 · Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting

  AbbVie · active not recruiting · Advanced Parkinson Disease · study director
• Ph2
  NCT06632951 · Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

  AbbVie · active not recruiting · Urothelial Carcinoma · study director
• Ph1
  NCT06632938 · A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intravenous (IV) Doses of ABBV-382 in Healthy Adult Chinese Volunteers

  AbbVie · completed · Healthy Volunteer · study director
• Ph2
  NCT06628310 · A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

  AbbVie · active not recruiting · Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma · study director
• Ph1
  NCT06618118 · A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder

  AbbVie · terminated · Major Depressive Disorder (MDD) · study director
• Ph2
  NCT06614192 · A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  AbbVie · active not recruiting · Metastatic Colorectal Cancer · study director
• Ph2
  NCT06605599 · Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

  AbbVie · completed · Bipolar I Disorder, Bipolar II Disorder · study director
• N/A
  NCT06603558 · Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

  AbbVie · recruiting · Chronic Migraine, Episodic Migraine, Migraine · study director
• N/A
  NCT06594016 · Expanded Access to Fosigotifator

  AbbVie · no longer available · Vanishing White Matter, Cree Leukoencephalopathy · study director
• Ph1
  NCT06579300 · A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

  AbbVie · terminated · Healthy Volunteer · study director
• N/A
  NCT06581042 · Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

  AbbVie · recruiting · Ulcerative Colitis, Crohn's Disease · study director
• Ph3
  NCT06575192 · Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants

  AbbVie · recruiting · Breast Reconstruction · study director
• Ph1
  NCT06571266 · A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph2
  NCT06568939 · A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  AbbVie · recruiting · Non-Small Cell Lung Cancer, c-MET · study director
• Ph2
  NCT06548542 · Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  AbbVie · recruiting · Crohn's Disease · study director
• N/A
  NCT06548568 · A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China

  AbbVie · active not recruiting · Diabetic Macular Edema · study director
• N/A
  NCT06543914 · Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

  AbbVie · active not recruiting · Migraine · study director
• Ph2/Ph3
  NCT06547125 · A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality

  AbbVie · completed · Skin Quality Deficit · study director
• Ph2
  NCT06524635 · A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

  AbbVie · recruiting · Hidradenitis Suppurativa, Atopic Dermatitis · study director
• Ph3
  NCT06508658 · A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  Genmab · active not recruiting · Diffuse Large B-Cell Lymphoma · study director
• N/A
  NCT06503536 · A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review

  AbbVie · completed · Atopic Dermatitis (AD) · study director
• Ph1
  NCT06487559 · A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

  AbbVie · terminated · Hepatocellular Carcinoma (HCC) · study director
• Ph1
  NCT06487572 · A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph1
  NCT06477926 · A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Participants

  AbbVie · completed · Healthy Volunteers · study director
• Ph3
  NCT06468228 · A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  AbbVie · active not recruiting · Hidradenitis Suppurativa · study director
• Ph1
  NCT06464692 · Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer

  AbbVie · active not recruiting · Colorectal Cancer · study director
• Ph3
  NCT06461897 · A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  AbbVie · active not recruiting · Atopic Dermatitis · study director
• N/A
  NCT06459297 · Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease

  AbbVie · completed · Ulcerative Colitis, Crohn's Disease · study director
• N/A
  NCT06443775 · An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

  AbbVie · completed · Dry Eye · study director
• N/A
  NCT06439966 · Expanded Access to ABBV-787

  AbbVie · no longer available · Acute Myeloid Leukemia · study director
• N/A
  NCT06439394 · An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

  AbbVie · completed · Dry Eye · study director
• Ph3
  NCT06428019 · A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

  AbbVie · recruiting · Chronic Lymphocytic Leukemia · study director
• N/A
  NCT06421740 · An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

  AbbVie · completed · Atopic Dermatitis · study director
• Ph1
  NCT06414798 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Participants.

  AbbVie · completed · Healthy Volunteers · study director
• Ph3
  NCT06417775 · Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  AbbVie · active not recruiting · Migraine · study director
• Ph1
  NCT06402513 · A Study in Healthy Adult Participants to Assess the Pharmacokinetics, Immunogenicity, Safety, and Tolerability of a Ravagalimab Subcutaneous Formulation in a Pre-Filled Syringe

  AbbVie · completed · Healthy Volunteers · study director
• Ph3
  NCT06399718 · A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

  AbbVie · completed · Masseter Muscle Prominence · study director
• Ph2
  NCT06395948 · A Study Evaluating APG777 in Atopic Dermatitis

  Apogee Therapeutics, Inc. · active not recruiting · Atopic Dermatitis · study director
• Ph3
  NCT06390722 · A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis

  AbbVie · withdrawn · Atopic Dermatitis, Sleep Disturbance · study director
• Ph3
  NCT06389136 · A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  AbbVie · active not recruiting · Atopic Dermatitis · study director
• Ph3
  NCT06387394 · A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

  AbbVie · completed · Masseter Muscle Prominence · study director

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.